N/A:CHMX
NEXT-ChemX Corporation.
A specialized chemical entity with substantial intangible assets but currently reporting zero revenue and significant operating losses over the last five years.
Key Metrics
Investment Thesis
Bull Case
Investors may view the stock as a deep-value turnaround play given the company's substantial asset base and historical equity contributions that are currently undervalued due to temporary operational headwinds. The presence of significant intangible assets suggests underlying intellectual property value that could be monetized once market conditions or specific product cycles align with revenue generation.
Bear Case
The stock is highly speculative given zero recorded revenue, massive current liabilities exceeding current assets by nearly 6x, and a consistent history of losses over the last five years. Without immediate evidence of revenue recovery or a credible path to profitability, the company faces an existential liquidity crisis that could lead to further dilution or insolvency.
About NEXT-ChemX Corporation.
NEXT-ChemX Corporation (CHMX) operates within the chemical manufacturing sector, focusing on specialized industrial solutions and process optimization services. The company serves markets requiring high-purity compounds and custom chemical formulations, though current filings show minimal recorded revenue streams in recent periods. Key products likely include niche intermediates or catalysts derived from its significant intangible asset base and long-term operational history.
Analysis
Management Discussion
The company reported a net loss of -$1.8M for 2024, continuing a trend of negative performance with losses widening to -$2.4M in 2023 before recovering slightly to -$1.7M in 2022. Cash flow from operations turned negative at -$1.5M while cash flow from financing provided a modest inflow of $1.6M, highlighting reliance on external capital rather than organic business generation.
Industry Overview
The specialty chemicals industry is characterized by high barriers to entry due to regulatory compliance, R&D intensity, and customer certification cycles. Companies in this space typically leverage proprietary formulations and long-term supply contracts to maintain margins, though CHMX currently lacks the revenue scale typical of established peers.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| Operating Expenses | $1.7M | $2.0M | $1.7M |
| Operating Income | $-1.7M | $-2.0M | $-1.7M |
| G&A | $1.7M | $2.0M | — |
| D&A | $5.2K | $5.3K | $155.1K |
| Depreciation | — | — | $7.3K |
| Other OpEx | $0 | $0 | — |
| Non-Operating Income | $-70.5K | $-384.6K | $-79.4K |
| Interest Expense | $70.5K | $87.7K | — |
| Pre-Tax Income | $-1.7M | $-2.4M | $-1.8M |
| Income Tax | $0 | $0 | $0 |
| Continuing Ops | $-1.7M | $-2.4M | $-1.8M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-1.7M | $-2.4M | $-1.8M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-1.7M | $-2.4M | $-1.8M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $50.5K | $140.3K | $705.5K |
| Prepaid Expenses | $22.2K | $72.9K | $604.4K |
| Other Current Assets | $28.4K | $67.4K | $101.1K |
| Long-Term Assets | $3.2M | $3.2M | $2.5M |
| PP&E (Net) | $18.0K | $12.6K | $7.3K |
| Intangibles | $3.2M | $3.2M | $2.5M |
| Other LT Assets | $0 | $0 | $0 |
| Total Assets | $3.2M | $3.3M | $3.3M |
| Current Liabilities | $2.5M | $3.9M | $4.6M |
| Accounts Payable | — | — | $165.1K |
| Other Current Liab | — | — | $4.4M |
| Long-Term Liabilities | $0 | $0 | $1.6M |
| Total Liabilities | $2.5M | $3.9M | $6.2M |
| Shareholders' Equity | $731.9K | $-629.4K | $-2.9M |
| Paid-In Capital | $4.4M | $5.4M | $5.4M |
| Retained Earnings | $-3.7M | $-6.1M | $-8.3M |
| Total L&E | $3.2M | $3.3M | $3.3M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-1.7M | $-2.4M | $-1.8M |
| Non-Cash Adjustments | $-36.0K | $338.9K | $-1.9M |
| Working Capital Changes | $844.7K | $1.5M | $2.2M |
| Cash from Operations | $-935.1K | $-544.9K | $-1.5M |
| Capital Expenditures | $1.6K | — | — |
| Cash from Investing | $-1.6K | $0 | $0 |
| Cash from Financing | $954.6K | $519.0K | $1.6M |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $17.9K | $-25.9K | $60.1K |
| Beginning Cash | $10.4K | $28.4K | $2.5K |
| Ending Cash | $28.4K | $2.5K | $62.5K |
Frequently Asked Questions
How does NEXT-ChemX Corporation. make money?
Specialized Chemical Synthesis, Process Engineering Services, and Strategic Technology Licensing based on the heavy weighting of operating net intangible assets relative to standard physical inventory.
What are the main risks for CHMX?
Severe liquidity risk with current liabilities of $4.6M against only $705k in current assets; persistent negative cash flow from operations (-$1.5M) over the trailing period; significant accumulated retained earnings deficit of -$8.3M indicating long-term profitability issues.
What is CHMX's competitive advantage?
Possession of $2.5M in operating net intangible assets suggesting proprietary patents or trade secrets; significant paid-in capital ($5.4M) indicating a strong historical equity base before recent erosion; substantial depreciation and amortization ($155,118) implying established fixed asset utilization.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.